查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574934

结核病检测市场，按检测类型、最终用户、国家和地区划分 - 2024-2032 年行业分析、市场规模、市场份额和预测

Tuberculosis Testing Market, By Test Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年结核病检测市场规模为22.9032亿美元，2024年至2032年复合年增长率为5.99%。

结核病检测市场-市场动态

抗药性结核菌株的日益普及推动了检测需求。

抗药性结核病（TB）菌株流行率的不断上升是结核病检测市场的重要推动力。随着这些抗药性菌株变得越来越常见，及时、准确的检测对于有效治疗至关重要。根据美国疾病管制与预防中心 (CDC) 的数据，美国新诊断的结核病病例中约有 3% 具有抗药性。这项统计数据凸显了对先进检测解决方案的迫切需求，以有效识别和管理抗药性菌株。医疗保健提供者需要可靠的诊断工具来确保适当的治疗并控制结核病的传播。随着意识的增强，对创新测试方法的需求将持续成长，支持市场成长。

结核病检测市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 5.99% 左右的复合年增长率成长

根据测试类型细分，预计分子诊断将在 2023 年显示最大的市场份额

根据最终用户细分，病理实验室是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

结核病检测市场-細項分析：

全球结核病检测市场根据检测类型、最终用户和地区进行细分。

市场根据测试类型分为七类：射线照相方法、诊断实验室方法、分子诊断、潜伏感染检测、细胞激素检测测定、抗药性检测（DST）、噬菌体测定和其他测试类型。在结核病检测市场中，分子诊断，特别是聚合酶链反应（PCR）方法，是最主要的部分。 PCR 因其检测结核分枝桿菌（即使是少量细菌）的速度和准确性而受到高度重视。这种方法可以快速诊断，这对于及时治疗和控制疾病传播至关重要。它识别抗药性的能力也增强了治疗选择。因此，PCR 在推动结核病诊断和改善患者治疗效果方面发挥关键作用。

市场根据最终用户分为几类：病理实验室、即时检测 (POCT) 和其他。在结核病检测市场中，病理实验室是最重要的环节。这些实验室对于执行各种测试至关重要，包括培养方法和分子诊断。它们可以处理许多样本并提供准确的结果，这对于诊断和管理结核病至关重要。他们的专业设备和训练有素的员工确保正确完成复杂的测试。由于结核病仍然是一个主要的健康问题，病理实验室的角色至关重要，使其成为市场的主导部分。

结核病检测市场-地理洞察

北美结核病检测市场专注于先进的诊断技术。美国和加拿大是该地区的领导者，在医疗保健和研究方面进行了大量投资。在美国，疾病管制与预防中心 (CDC) 促进结核病检测和预防，提高人们对疾病的认识。对快速检测方法（例如分子诊断）的需求日益增长，这有助于快速识别病例。政府计画和资金也支持检测，特别是针对高风险族群。市场上的主要公司推动创新并使测试变得更容易。总体而言，北美在改善结核病检测和治疗工作方面发挥着重要作用。

结核病检测市场-竞争格局：

结核病检测市场具有竞争格局，有几个主要参与者。 Thermo Fisher Scientific 和 Roche 等公司在提供先进诊断工具方面处于领先地位。 Abbott Laboratories 和 BD 提供一系列有助于有效检测结核病的检查。 Cepheid 以其快速分子检测解决方案而闻名，该解决方案正变得越来越受欢迎。

Hologic 和 QIAGEN 也贡献创新技术来提高测试准确性。其他着名的参与者包括 BioMerieux 和 OxfordImmuntec，专注于专门的测试方法。这种产品的多样性有助于满足全球对高效结核病诊断不断增长的需求。

最新进展：

2023 年 11 月，BD 和 Bio Farma 签署了一份谅解备忘录 (MOU)，共同致力于解决结核病问题。 BD 提供了先进的结核病诊断工具，而这项合作改善了印尼结核病解决方案的供应链。

2023年2月，Fisher Scientific在印度推出即时PCR试剂盒，用于检测各种传染病。这些试剂盒涵盖一系列疾病，包括基因分析 (HLA B27)、多重抗药性结核病 (MTB MDR)、B型肝炎病毒 (HBV)、结核分枝桿菌复合体 (MTB)、人类免疫缺乏病毒(HIV)和丙型肝炎病毒（HCV）。

目录

第一章：结核病检测市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按测试类型分類的结核病测试市场片段
    • 最终用户的结核病检测市场片段
    • 按国家/地区分類的结核病检测市场片段
    • 按地区分類的结核病检测市场片段
  • 竞争洞察

第 3 章：结核病检测主要市场趋势

  • 结核病检测市场驱动因素
    • 市场驱动因素的影响分析
  • 结核病检测市场限制
    • 市场限制影响分析
  • 结核病检测市场机会
  • 结核病检测市场未来趋势

第 4 章：结核病检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：结核病检测市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：结核病检测市场格局

  • 2023 年结核病检测市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：结核病检测市场 - 按检测类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 射线照相法
    • 诊断实验室方法
      • 显微镜检查
      • 基于文化的技术
      • 血清学检测
    • 分子诊断
      • 聚合酶炼式反应 (PCR)
      • 核酸扩增检验（NAAT）
      • GeneXpert MTB/RIF
    • 检测潜伏感染
      • 结核菌素皮肤试验（TST）
      • 干扰素-γ释放测定（IGRA）
    • 细胞激素检测分析
    • 抗药性检测（DST）
    • 噬菌体测定
    • 其他的

第 8 章：结核病检测市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 病理实验室
    • 即时检测 (POCT)
    • 其他的

第 9 章：结核病检测市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美结核病检测主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲结核病检测主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区结核病检测主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 按测试类型分類的亚太市场规模和预测
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲结核病检测主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按测试类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲结核病检测主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按测试类型）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 结核病检测产业

  • 竞争仪表板
  • 公司简介
    • Thermo Fisher Scientific
    • Roche
    • Abbott Laboratories
    • BD (Becton, Dickinson and Company)
    • Hologic
    • Cepheid
    • QIAGEN
    • Molecular Testing Labs
    • Siemens Healthineers
    • Genomictree
    • BioMerieux
    • Oxford Immunotec
    • F. Hoffmann-La Roche AG
    • Eiken Chemical Co., Ltd.
    • Hain Lifescience GmbH

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3933

REPORT HIGHLIGHT

Tuberculosis Testing Market size was valued at USD 2,290.32 million in 2023, expanding at a CAGR of 5.99% from 2024 to 2032.

The tuberculosis (TB) testing market refers to the industry that provides various tests to diagnose TB, a serious infectious disease that mainly affects the lungs. This market includes different types of tests, such as skin tests, blood tests, and imaging tests like X-rays. The demand for TB testing has increased due to the rising number of TB cases worldwide and the need for early detection and treatment. Many organizations, including governments and health agencies, invest in TB testing to control the disease. Overall, the TB testing market plays a crucial role in public health by helping to identify and treat those affected by the disease.

Tuberculosis Testing Market- Market Dynamics

The increasing prevalence of drug-resistant tuberculosis strains drives testing demand.

The increasing prevalence of drug-resistant tuberculosis (TB) strains is a significant driver for the tuberculosis testing market. As these resistant strains become more common, timely and accurate testing is essential for effective treatment. According to the Centers for Disease Control and Prevention (CDC), about 3% of newly diagnosed TB cases in the U.S. are drug-resistant. This statistic highlights the urgent need for advanced testing solutions to identify and manage resistant strains effectively. Healthcare providers require reliable diagnostic tools to ensure appropriate treatment and control the spread of TB. As awareness grows, the demand for innovative testing methods will continue to rise, supporting market growth.

Tuberculosis Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.99% over the forecast period (2024-2032)

Based on Test Type segmentation, Molecular diagnostics was predicted to show maximum market share in the year 2023

Based on End-user segmentation, Pathological laboratories was the leading type in 2023

Based on Region, North America was the leading revenue generator in 2023

Tuberculosis Testing Market- Segmentation Analysis:

The Global Tuberculosis Testing Market is segmented based on Test Type, End User, and Region.

The market is divided into Seven categories based on Test Type: Radiographic method, Diagnostic laboratory methods, Molecular diagnostics, Detection of latent infection, Cytokine detection assay, Detection of drug resistance (DST), Phage assay, and other test types. In the tuberculosis testing market, Molecular diagnostics, particularly the Polymerase Chain Reaction (PCR) method, is the most dominant segment. PCR is highly valued for its speed and accuracy in detecting Mycobacterium tuberculosis, even in small amounts of bacteria. This method allows for quick diagnosis, which is crucial for initiating timely treatment and controlling the spread of the disease. Its ability to identify drug resistance also enhances treatment options. As a result, PCR plays a key role in advancing tuberculosis diagnostics and improving patient outcomes.

The market is divided into categories based on End Users: Pathological laboratories, Point of care testing (POCT), and Others. In the tuberculosis testing market, pathological laboratories are the most important segment. These labs are essential for performing various tests, including culture methods and molecular diagnostics. They can handle many samples and provide accurate results, which is vital for diagnosing and managing TB. Their specialized equipment and trained staff ensure that complex tests are done correctly. As TB continues to be a major health issue, the role of pathological laboratories is crucial, making them the leading segment in the market.

Tuberculosis Testing Market- Geographical Insights

The North American tuberculosis testing market focuses on advanced diagnostic technologies. The United States and Canada are the leaders in this region, with significant investments in healthcare and research. In the U.S., the Centers for Disease Control and Prevention (CDC) promotes TB testing and prevention, raising awareness about the disease. There is a growing need for rapid testing methods, like molecular diagnostics, which help identify cases quickly. Government programs and funding also support testing, especially for high-risk groups. Major companies in the market drive innovation and make testing more accessible. Overall, North America plays an important role in improving tuberculosis testing and treatment efforts.

Tuberculosis Testing Market- Competitive Landscape:

The tuberculosis testing market features a competitive landscape with several key players. Companies like Thermo Fisher Scientific and Roche lead in providing advanced diagnostic tools. Abbott Laboratories and BD offer a range of tests that help detect TB effectively. Cepheid is known for its rapid molecular testing solutions, which are becoming increasingly popular.

Hologic and QIAGEN also contribute innovative technologies to improve testing accuracy. Other notable players include BioMerieux and Oxford Immunotec, focusing on specialized testing methods. This diversity in offerings helps meet the growing demand for efficient tuberculosis diagnostics worldwide.

Recent Developments:

In November 2023, BD and Bio Farma signed a memorandum of understanding (MOU) to work together on addressing tuberculosis. BD offered access to its advanced TB diagnostic tools, while the partnership improved the supply chain for TB solutions in Indonesia.

In February 2023, Fisher Scientific launched real-time PCR kits in India for detecting various infectious diseases. These kits cover a range of conditions, including genetic analysis (HLA B27), Multi-Drug-Resistant Tuberculosis (MTB MDR), Hepatitis B Virus (HBV), M. Tuberculosis complex (MTB), Human Immunodeficiency Virus (HIV), and Hepatitis C Virus (HCV).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TUBERCULOSIS TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Roche
  • Abbott Laboratories
  • BD (Becton, Dickinson, and Company)
  • Hologic
  • Cepheid
  • QIAGEN
  • Molecular Testing Labs
  • Siemens Healthineers
  • Genomictree
  • BioMerieux
  • Oxford Immunotec
  • F. Hoffmann-La Roche AG
  • Eiken Chemical Co., Ltd.
  • Hain Lifescience GmbH

GLOBAL TUBERCULOSIS TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Radiographic method
  • Diagnostic laboratory methods
  • Microscopy
  • Culture-based techniques
  • Serological tests
  • Molecular diagnostics
  • Polymerase chain reaction (PCR)
  • Nucleic acid amplification tests (NAAT)
  • GeneXpert MTB/RIF
  • Detection of latent infection
  • Tuberculin skin test (TST)
  • Interferon-gamma release assays (IGRAs)
  • Cytokine detection assay
  • Detection of drug resistance (DST)
  • Phage assay
  • Others

GLOBAL TUBERCULOSIS TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pathological laboratories
  • Point of care testing (POCT)
  • Others

GLOBAL TUBERCULOSIS TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Tuberculosis Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Tuberculosis Testing Market Snippet by Test Type
    • 2.1.2. Tuberculosis Testing Market Snippet by End User
    • 2.1.3. Tuberculosis Testing Market Snippet by Country
    • 2.1.4. Tuberculosis Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Tuberculosis Testing Key Market Trends

  • 3.1. Tuberculosis Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Tuberculosis Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Tuberculosis Testing Market Opportunities
  • 3.4. Tuberculosis Testing Market Future Trends

4. Tuberculosis Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tuberculosis Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Tuberculosis Testing Market Landscape

  • 6.1. Tuberculosis Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Tuberculosis Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Radiographic method
    • 7.1.3. Diagnostic laboratory methods
      • 7.1.3.1. Microscopy
      • 7.1.3.2. Culture-based techniques
      • 7.1.3.3. Serological tests
    • 7.1.4. Molecular diagnostics
      • 7.1.4.1. Polymerase chain reaction (PCR)
      • 7.1.4.2. Nucleic acid amplification tests (NAAT)
      • 7.1.4.3. GeneXpert MTB/RIF
    • 7.1.5. Detection of latent infection
      • 7.1.5.1. Tuberculin skin test (TST)
      • 7.1.5.2. Interferon-gamma release assays (IGRAs)
    • 7.1.6. Cytokine detection assay
    • 7.1.7. Detection of drug resistance (DST)
    • 7.1.8. Phage assay
    • 7.1.9. Others

8. Tuberculosis Testing Market - By End User

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 8.1.2. Pathological laboratories
    • 8.1.3. Point of care testing (POCT)
    • 8.1.4. Others

9. Tuberculosis Testing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Tuberculosis Testing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Tuberculosis Testing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Tuberculosis Testing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Tuberculosis Testing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Tuberculosis Testing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Tuberculosis Testing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific
    • 10.2.2. Roche
    • 10.2.3. Abbott Laboratories
    • 10.2.4. BD (Becton, Dickinson and Company)
    • 10.2.5. Hologic
    • 10.2.6. Cepheid
    • 10.2.7. QIAGEN
    • 10.2.8. Molecular Testing Labs
    • 10.2.9. Siemens Healthineers
    • 10.2.10. Genomictree
    • 10.2.11. BioMerieux
    • 10.2.12. Oxford Immunotec
    • 10.2.13. F. Hoffmann-La Roche AG
    • 10.2.14. Eiken Chemical Co., Ltd.
    • 10.2.15. Hain Lifescience GmbH

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us